Immunovia AB: Immunovia to discuss adoption of IMMray PanCan-d with key opinion leaders on May 3, 2023

LUND, Sweden, April 26, 2023 /PRNewswire/ -- Immunovia (Nasdaq Stockholm: IMMNOV), the diagnostics company that has launched the world's first test dedicated to the early detection of pancreatic

Related Keywords

Sweden ,United States ,Stockholm ,Immray Pancan D ,Karin Almqvist Liwendahl ,Cheryl Meguid ,Philipp Mathieu ,David Bakelman ,Rosario Ligresti ,Hackensack University Medical Center ,University Of Colorado Anschutz Medical Campus ,Immunovia Inc ,National Pancreas Foundation ,Nasdaq Stockholm ,Pancreatic Cancer High Risk Screening ,Medical Director ,Oncology Multidisciplinary ,Clinic Coordinator ,Colorado Anschutz Medical ,Immunovia ,Iscuss ,Adoption ,Immray ,Cancan ,Opinion ,Leaders ,023 ,